Phase I Trial of BAY1251152 for Advanced Blood Cancers (Q66405492)
Jump to navigation
Jump to search
clinical trial
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase I Trial of BAY1251152 for Advanced Blood Cancers |
clinical trial |
Statements
An Open-label, Multicenter Phase I Study to Characterize the Safety, Tolerability, Preliminary Anti-tumor Activity, Pharmacokinetics and Maximum Tolerated Dose of BAY1251152 in Patients With Advanced Hematological Malignancies (English)
0 references
17 June 2016
0 references
3 August 2018
0 references
21
0 references
18 year
0 references